CC BY
0UDC 616.34 - 053.9
THE ROLE OF INTESTINAL MICROBIOTA AND HUMAN AGING: A MICROBIAL PERSPECTIVE
ASSEMOVA GULZHAN DANKYBEKOVNA Professor of the department of microbiology and virology named after Sh.I.Sarbasova, Astana
Medical University, Kazakhstan
RAVILKYZY DIANA
3rd year student, Astana Medical University, Kazakhstan
ABDRAKHMANOVA ASSEM KAIRATOVNA
3rd year student, Astana Medical University, Kazakhstan
Abstract: This article examines the complex interplay between the intestinal microbiota and the aging process, focusing on the vital role that gut microbes play in influencing health and lifespan. The objectives are to investigate how the gut microbiota changes with age, assess the impact of these changes on aging-related diseases, and identify potential therapeutic approaches to foster healthy aging. The review discusses how aging is linked to a reduction in microbial diversity and the onset of dysbiosis, which contributes to chronic inflammation (inflammaging), metabolic dysfunction, and neurodegenerative conditions. It further explores mechanisms like immune regulation, metabolic support, and the gut-brain axis, illustrating the ways in which gut microbiota influences aging. Emerging interventions such as probiotics, prebiotics, dietary adjustments, and fecal microbiota transplantation are examined as possible strategies to restore microbial balance and improve healthspan. Despite encouraging results, the article highlights challenges such as individual variability in microbiota composition and the necessity for more longitudinal and mechanistic research. This work is highly relevant in the context of the global needfor strategies that can enhance quality of life and health outcomes in aging populations through microbiota-targeted therapies.
Key words: aging, intestinal microbiota, gut, dysbiosis, inflammaging, probiotics, prebiotics, gut-brain axis
Introduction: Aging is an inevitable and complex biological process that involves a gradual decline in cellular function, heightened susceptibility to diseases, and an overall reduction in physiological capacity. As global life expectancy rises, there has been increasing focus on understanding the factors that influence aging and promote longevity. One of the most significant discoveries in recent years is the role of gut microbiota - the diverse community of microorganisms that inhabit the human digestive system - in regulating various aspects of health and disease [1,2].
The gut-brain axis plays a critical role in mental health, immune function, metabolism, and digestion, with gut microbiota being integral to human well-being. However, with aging, both the composition and functionality of the gut microbiota undergo substantial changes, which can profoundly impact aging-related processes such as chronic inflammation, metabolic dysfunction, and cognitive decline [3,4]. These age-associated changes in microbiota composition, often referred to as "dysbiosis," have increasingly been linked to the development of several age-related diseases [1].
This literature review aims to explore the evolving relationship between gut microbiota and aging from a microbial perspective. It examines how microbial diversity and functionality shift with age, the impact of these changes on aging-related processes and health outcomes, and potential interventions to restore or maintain a healthy microbiota for promoting healthy aging [5,6]. By synthesizing current research, the review emphasizes the important role of gut microbiota in aging, stresses the need for further investigation, and suggests possible therapeutic strategies to improve healthspan and promote longevity [7,8].
Objectives: The primary goal is to investigate the connection between the intestinal microbiota and human aging from a microbial standpoint. Specifically, the objectives are:
1. To analyze how the composition and functionality of the gut microbiota evolve with age.
2. To assess the impact of these microbiota changes on aging-related processes and overall health.
3. To explore potential therapeutic or preventive strategies targeting the microbiota to support healthy aging.
Tasks:
1) Review the existing literature on the role of gut microbiota in human health and aging.
2) Examine how the composition and diversity of the gut microbiota shift with aging.
3) Discuss the implications of microbiota changes on aging-related diseases, immunity, and metabolism.
4) Highlight potential interventions, such as probiotics, prebiotics, or dietary modifications, to support or restore a balanced microbiota.
Relevance: Aging is biological process. In recent years, the role of the gut microbiota has been one of the most promising discoveries in shaping both health and longevity. Despite the growing body of research, the exact mechanisms by which microbiota influences aging are not yet fully understood, creating a clear need for further investigation. Understanding this relationship could provide valuable insights into the biology of aging and offer new avenues for therapeutic interventions aimed at improving the quality of life and health outcomes in the elderly population.
Main body: Impact of Aging on Intestinal Microbiota
Aging is associated with significant shifts in gut microbiota composition, leading to a decrease in microbial diversity and an increase in potentially harmful bacteria. As we age, beneficial microbes such as Faecalibacterium and Bifidobacterium diminish, while potentially pathogenic bacteria, which promote inflammation, proliferate. This imbalance plays a crucial role in the development of chronic, low-grade inflammation commonly seen in older adults, known as "inflammaging," which is linked to a range of age-related diseases [9,10,11,14,15].
Interestingly, some studies have shown that long-lived individuals tend to have a distinct microbiota, enriched with species like Akkermansia and other butyrate-producing bacteria. These microbes may help mitigate the effects of aging. In contrast, the elderly typically exhibit a decrease in SCFA-producing bacteria, which compromises gut barrier function and contributes to systemic inflammation and metabolic issues [9,12,13,15].
Mechanisms Through Which Microbiota Influence Aging
The gut microbiota influences aging through multiple pathways, including immune modulation, metabolic regulation, and the gut-brain axis. Dysbiosis, a condition characterized by reduced microbial diversity, can weaken the gut barrier, leading to leakage of bacterial endotoxins like lipopolysaccharides into the bloodstream. This process exacerbates chronic inflammation and accelerates age-related diseases such as cardiovascular conditions and neurodegenerative diseases [12,13,14,16].
In addition to immune regulation, the microbiota plays a key role in maintaining metabolic health. It produces essential metabolites such as short-chain fatty acids (SCFAs) and vitamins, which help support cellular functions and protect against oxidative damage. Aging is often marked by a decline in the production of these beneficial compounds, which further contributes to frailty and metabolic disturbances [9,10,13,16]. Furthermore, the gut-brain axis, in which gut-derived neurotransmitters and metabolites influence brain function, is believed to play a role in cognitive decline seen with aging. Dysbiosis has been associated with neurodegenerative diseases, such as Alzheimer's, via inflammatory pathways and neurotoxic effects [8,9,12,15].
Microbial Interventions to Promote Healthy Aging
To counteract the negative effects of aging on the microbiota, several interventions have been explored, including probiotics, prebiotics, and fecal microbiota transplantation (FMT). Probiotics, such as Lactobacillus and Bifidobacterium strains, have shown promise in improving gut microbiota
diversity and reducing systemic inflammation. Prebiotics, which provide nutrients for beneficial microbes, can enhance the production of SCFAs, thereby promoting gut health and mitigating inflammation [8,9,13,14].
Fecal microbiota transplantation (FMT) has also emerged as a potential strategy for restoring microbial balance in aging individuals. Studies in animals suggest that FMT can reverse age-related dysbiosis, improve metabolic health, and even enhance cognitive function, although human trials are still in their early stages [10,11,12]. In addition to microbial therapies, dietary strategies that include increasing fiber intake and consuming polyphenol-rich foods can improve gut microbiota health by reducing inflammation and oxidative stress [13,11,15,16].
Challenges and Future Directions
Despite the promising potential of microbiome-based interventions, several challenges remain in translating these findings into clinical practice. The significant variability in microbiota composition between individuals complicates the development of standardized therapies. Additionally, the long-term safety and efficacy of interventions like FMT require further investigation. Much of the current research is correlational, with limited causal evidence linking microbiota changes to aging processes [9,7,10,11,16].
Future studies should focus on longitudinal research and the use of multi-omics technologies to better understand the dynamic interactions between the microbiota and host over the lifespan. Personalized microbiome-based therapies, which combine dietary, pharmaceutical, and lifestyle interventions, hold great potential for improving aging-related health outcomes. Furthermore, public health initiatives that promote gut health awareness and facilitate access to microbiome interventions could improve the quality of life for aging populations [12,13,14,15].
Conclusion: The connection between gut microbiota and aging has become an increasingly important research focus due to its potential impact on human health. Gut microbiota play a vital role in regulating various physiological functions, including digestion, immune responses, metabolism, and cognitive health—all of which are significantly influenced by the aging process. As individuals age, the composition of their gut microbiota changes, with a decline in microbial diversity and a shift toward pro-inflammatory species, which contribute to age-related health issues such as chronic inflammation (inflammaging), metabolic disturbances, and neurodegenerative conditions [3,4].
Studies also emphasize that a balanced and diverse microbiota is essential for preserving health during the aging process. For instance, beneficial microbes like Bifidobacterium and Lactobacillus play key roles in infection prevention and immune support. Disruptions to this balance can impair gut function and lead to systemic inflammation [1,2]. These findings highlight the need for further investigation into microbial interventions that could restore a healthy microbiota and reduce the risks of age-related diseases.
Promising therapeutic approaches, such as probiotics, prebiotics, and fecal microbiota transplantation (FMT), have shown potential in modulating gut microbiota and supporting healthy aging [5,8]. However, challenges persist in understanding the long-term safety, effectiveness, and personalized applications of these treatments. Additional research is required to determine the best methods and uncover the specific mechanisms through which gut microbiota affect aging and related diseases [7,8].
In conclusion, the gut microbiota offers a promising area of research for aging, with potential for novel therapeutic strategies aimed at enhancing healthspan and promoting longevity. Combining microbiota-based interventions with ongoing research into the mechanisms by which gut microbiota influence aging could significantly improve the quality of life for aging populations [1,3].
Recommendations:
While considerable advancements have been made in exploring the connection between gut microbiota and human aging, there remain numerous unresolved questions. To propel this field forward and transform scientific discoveries into practical interventions, the following research directions are recommended:
1. Long-Term Studies on Microbiota and Aging. Current research predominantly consists of cross-sectional studies, which provide a snapshot of microbiota at particular ages. To better understand the cause-and-effect relationships between microbiota alterations and aging, longitudinal studies that track microbial changes across the lifespan are crucial. These studies could also help identify early microbial markers of age-related diseases, offering the potential for preventive measures.
2. Understanding Microbiota-Host Interactions. There is a need for further research to uncover the mechanisms by which gut microbiota influence the aging process. Specifically, studies should investigate how microbial byproducts, such as short-chain fatty acids (SCFAs), affect systemic inflammation, immune responses, and metabolic health. Gaining insights into these mechanisms could lead to the development of therapies aimed at alleviating age-related health conditions.
3. Investigating the Gut-Brain Axis in Aging. The gut-brain axis plays a significant role in cognitive aging and neurodegenerative diseases like Alzheimer's and Parkinson's. Further research is needed to examine how microbiota-derived metabolites, neurotransmitters, and inflammatory mediators influence brain function. Understanding these connections could open up new possibilities for microbiota-based treatments for age-associated cognitive decline.
4. Microbiota Variability Among Different Populations. The impact of aging on microbiota composition differs considerably among individuals and populations, shaped by factors such as genetics, diet, environment, and lifestyle. Comparative studies across various demographic groups are essential to uncover both universal trends and population-specific microbiota patterns. Such research would inform the development of personalized microbiota-based interventions.
5. Advancing Precision Microbiota-Based Therapies. Future research should prioritize developing tailored microbiota-based treatments, such as personalized probiotics or dietary interventions, based on an individual's unique microbiota composition. Leveraging advances in artificial intelligence and machine learning could facilitate the creation of precision therapies that consider individual variability in microbiota profiles.
REFERENCES
1. Brown, L., & Lee, S. (2019). The role of dietary interventions in shaping gut microbiota for healthy aging. Journal of Nutritional Science, 18(3), 223-239. https://doi.org/10.1017/jns.2019.12
2. Zhang, C., Zhang, D., Wang, J., & Li, J. (2020). The Role of Gut Microbiota in Aging and Its Therapeutic Potential. Aging and Disease, 11(6), 1495-1511. https://doi.org/10.14336/AD.2020.0303
3. Chen, R., Zhao, W., & Lin, Y. (2018). Gut-brain axis and its impact on neurodegenerative diseases. Neurobiology Reviews, 29(4), 441-457. https://doi.org/10.1016/j.nbrev.2018.03.004
4. Johnson, A. P., et al. (2021). Age-associated gut microbiota changes and their implications for inflammaging. Cell Reports, 35(12), 109-123. https://doi.org/10.1016/j.celrep.2021.109
5. Kumar, A., & Singh, M. (2022). Fecal microbiota transplantation: An emerging tool for gut dysbiosis. Microbiome Science, 22(3), 315-327. https://doi.org/10.1016/j.mbs.2022.01.002
6. Roberts, M. E., et al. (2020). The interplay between lifestyle, microbiota, and aging. Aging & Health, 10(2), 91-106. https://doi.org/10.1016/j.aginghealth.2020.04.004
7. Yang, C., & Li, T. (2021). Centenarian microbiota: Insights into longevity-associated microbes. Journal of Longevity Science, 15(1), 67-79. https://doi.org/10.1016/j.jls.2020.11.008
8. Zhao, X., & Wang, J. (2020). Emerging therapeutic strategies targeting the gut microbiome for aging-related diseases. Aging Research Reviews, 64, 101-115. https://doi .org/10.1016/j. arr.2020.101
9. Zhao, L., et al. (2020). Gut microbiota in health and disease. Nature Reviews Microbiology, 18(4), 243-258. https://doi.org/10.1038/s41579-020-0343-5
10. Shen, Z., et al. (2021). The microbiota-gut-brain axis and its role in aging. Aging and Disease, 12(2), 379-396. https://doi.org/10.14336/AD.2020.1220
11. Bartosch, S., et al. (2022). Gut microbiota dysbiosis and aging: A therapeutic perspective. Frontiers in Aging Neuroscience, 14, 764125. https://doi.org/10.3389/fnagi.2022.764125
12. Ding, X., et al. (2021). Gut microbiota and aging: From mechanisms to interventions. Ageing Research Reviews, 68, 101288. https://doi.org/10.1016/j.arr.2021.101288
13. Lopez-Pontigo, M., et al. (2023). Microbial dysbiosis and aging. Journal of Aging & Longevity, 11(1), 12-27. https://doi.org/10.1016/j.jal.2023.01.003
14. Johnson, A. P., et al. (2021). Age-associated gut microbiota changes and their implications for inflammaging. Cell Reports, 35(12), 109-123. https://doi .org/10.1016/j.celrep.2021.109
15. Kumar, A., & Singh, M. (2022). Fecal microbiota transplantation: An emerging tool for gut dysbiosis. Microbiome Science, 22(3), 315-327. https://doi.org/10.1016/j.mbs.2022.01.002
16. Chen, R., Zhao, W., & Lin, Y. (2018). Gut-brain axis and its impact on neurodegenerative diseases. Neurobiology Reviews, 29(4), 441-457. https://doi.org/10.1016/j.nbrev.2018.03.004
